Phoenix Holdings Ltd. Uro Gen Pharma Ltd. Transaction History

Phoenix Holdings Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$9.03 - $19.13 $111,547 - $236,312	-12,353 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$14.31 - $18.39 $5.24 Million - $6.73 Million	-365,985 Reduced 96.73%	12,353 $208,000
Q2 2021 Aug 10, 2021	SELL	$15.2 - $20.94 $3.65 Million - $5.03 Million	-240,380 Reduced 38.85%	378,338 $5.78 Million
Q1 2021 May 10, 2021	SELL	$17.99 - $26.96 $3.62 Million - $5.42 Million	-200,964 Reduced 24.52%	618,718 $12 Million
Q4 2020 Feb 11, 2021	SELL	$17.54 - $25.43 $1.44 Million - $2.09 Million	-82,297 Reduced 9.12%	819,682 $14.8 Million
Q3 2020 Nov 10, 2020	BUY	$18.81 - $26.42 $84,927 - $119,286	4,515 Added 0.5%	901,979 $16.4 Million
Q2 2020 Aug 10, 2020	BUY	$16.5 - $29.7 $230,934 - $415,681	13,996 Added 1.58%	897,464 $22.3 Million
Q1 2020 May 20, 2020	BUY	$13.68 - $34.6 $666,612 - $1.69 Million	48,729 Added 5.84%	883,468 $15.4 Million
Q4 2019 Feb 18, 2020	BUY	$21.11 - $34.86 $3.25 Million - $5.37 Million	154,007 Added 22.62%	834,739 $27.7 Million
Q3 2019 Nov 18, 2019	BUY	$23.83 - $36.44 $16.2 Million - $24.8 Million	680,732 New	680,732 $15.5 Million

128

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $255M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.